The collecting duct is the major source of prorenin in diabetes

Hypertension

Volumn 51, Issue 6, 2008, Pages 1597-1604

  Kang, Jung J ^a   Toma, Ildikó ^a   Sipos, Arnold ^a   Meer, Elliott J ^a   Vargas, Sarah L ^a   Peti Peterdi, János ^a  

^a UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

Author keywords

Collecting duct; Diabetes; Hypertension; Prorenin; Quinacrine; Renin

Indexed keywords

ANGIOTENSIN RECEPTOR ANTAGONIST; OLMESARTAN; PRORENIN; TRYPSIN; ANGIOTENSIN II; IMIDAZOLE DERIVATIVE; MEPACRINE; RENIN; TETRAZOLE DERIVATIVE; VASOCONSTRICTOR AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DIABETES MELLITUS; ENZYME ACTIVITY; HYPERPLASIA; JUXTAGLOMERULAR CELL; KIDNEY COLLECTING TUBULE; KIDNEY SLICE; MULTIPHOTON MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; ANIMAL; CELL CULTURE; CELL DIVISION; CYTOLOGY; DIABETIC NEPHROPATHY; DISEASE MODEL; EXPERIMENTAL DIABETES MELLITUS; FLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; JUXTAGLOMERULAR APPARATUS; METABOLISM; PHYSIOLOGY; RENOVASCULAR HYPERTENSION; WISTAR RAT;

ANGIOTENSIN II; ANGIOTENSIN II TYPE 1 RECEPTOR BLOCKERS; ANIMALS; CELL DIVISION; CELLS, CULTURED; DIABETES MELLITUS, EXPERIMENTAL; DIABETIC NEPHROPATHIES; DISEASE MODELS, ANIMAL; HYPERTENSION, RENAL; IMIDAZOLES; IMMUNOHISTOCHEMISTRY; JUXTAGLOMERULAR APPARATUS; KIDNEY TUBULES, COLLECTING; MICROSCOPY, FLUORESCENCE; QUINACRINE; RATS; RATS, WISTAR; RENIN; TETRAZOLES; TRYPSIN; VASOCONSTRICTOR AGENTS;

EID: 45849143635     PISSN: 0194911X     EISSN: None     Source Type: Journal    
DOI: 10.1161/HYPERTENSIONAHA.107.107268     Document Type: Article

References (32)

1. Hobart PM, Fogliano M, O'Connor BA, Schaefer IM, Chirgwin JM. Human renin gene: structure and sequence analysis. Proc Natl Acad Sci USA. 1984;81:5026-5030.
2. Schnermann J, and Briggs JP. Function of the juxtaglomerular apparatus: control of glomerular hemodynamics and renin secretion. In: Alpern RJ, Hebert SC, eds. The Kidney Physiology and Pathophysiology. Burlington, MA: Elsevier Academic Press; 2008:589-626.
3. Schweda F, Friis U, Wagner C, Skott O, Kurtz A. Renin release. Physiology (Bethesda). 2007;22:310-319.
4. Prieto-Carrasquero MC, Harrison-Bernard LM, Kobori H, Ozawa Y, Hering-Smith KS, Hamm LL, Navar LG. Enhancement of collecting duct renin in angiotensin II-dependent hypertensive rats. Hypertension. 2004; 44:223-229.
5. Rohrwasser A, Morgan T, Dillon HF, Zhao L, Callaway CW, Hillas E, Zhang S, Cheng T, Inagami T, Ward K, Terreros DA, Lalouel JM. Elements of a paracrine tubular renin angiotensin system along the entire nephron. Hypertension. 1999;34:1265-1274.
6. Zimpelmann J, Kumar D, Levine DZ, Wehbi G, Imig JD, Navar LG, Burns KD. Early diabetes mellitus stimulates proximal tubule renin mRNA expression in the rat. Kidney Int. 2000;58:2320-2330.
7. Ritz E, Dikow R. Hypertension and antihypertensive treatment of diabetic nephropathy. Nat Clin Pract Nephrol. 2006;2:562-567.
8. Gurley SB, Coffman TM. The renin-angiotensin system and diabetic nephropathy. Semin Nephrol. 2007;27:144-152.
9. Price DA, Porter LE, Gordon M, Fisher NDL, De'Oliveira JMF, Laffel LMB, Passan DR, Williams GH, Hollenberg NK. The paradox of the low-renin state in diabetic nephropathy. J Am Soc Nephrol. 1999;10:2382-2391.
10. Luetscher JA, Kraemer FB, Wilson DM, Schwartz HC, Bryer-Ash M. Increased plasma inactive renin in diabetes mellitus. A marker of micro-vascular complications. N Engl J Med. 1985;312:1412-1417.
11. Danser AH, Deinum J. Renin, prorenin and the putative (pro)renin receptor. Hypertension. 2005;46:1069 -1076.
12. Peti-Peterdi J, Fintha A, Fuson AL, Tousson A, Chow RH. Real-time imaging of renin release in vitro. Am J Physiol Renal Physiol. 2004;287:F329-F335.
13. Kang JJ, Toma I, Sipos A, McCulloch F, Peti-Peterdi J. Quantitative imaging of basic functions in renal (patho)physiology. Am J Physiol Renal Physiol. 2006;291:F495-F502.
14. Alund M. Juxtaglomerular cell activity during hemorrhage and ischemia as revealed by quinacrine histofluorescence. Acta Physiol Scand. 1980; 110:113-121.
15. Kobori H, Harrison-Bernard LM, Navar LG. Enhancement of angioten- sinogen expression in angiotensin II-dependent hypertension. Hypertension. 2001;37:1329-1335.
16. McCulloch F, Chambrey R, Eladari D, Peti-Peterdi J. Localization of connexin 30 in the luminal membrane of cells in the distal nephron. Am J Physiol Renal Physiol. 2005;289:F1304-F1312.
17. Suzuki F, Nakagawa T, Kakidachi H, Murakami K, Inagami T, Nakamura Y. The dominant role of the prosegment of prorenin in determining the rate of activation by acid or trypsin: studies with molecular chimeras. Biochem Biophys Res Commun. 2000;267:577-580.
18. Kim HS, Lee G, John SW, Maeda N, Smithies O. Molecular phenotyping for analyzing subtle genetic effects in mice: application to an angioten-sinogen gene titration. Proc Natl Acad Sci U S A. 2002;99:4602-4607.
19. Navar LG, Harrison-Bernard LM, Wang CT, Cervenka L, Mitchell KD. Concentrations and actions of intraluminal angiotensin II. JAmSoc Nephrol. 1999;10(suppl 11):S189-S195.
20. Jutras I, Seidah NG, Reudelhuber TL, Brechler V. Two activation states of the prohormone convertase PC1 in the secretory pathway. J Biol Chem. 1997;272:15184-15188.
21. M0nster Christensen B, Kim Y-H, Kwon T-H, Nielsen S. Lithium treatment induces a marked proliferation of primarily principal cells in rat kidney inner medullary collecting duct. Am J Physiol Renal Physiol. 2006;291:F39-F48.
22. Toffelmire EB, Slater K, Corvol P, Menard J, Schambelan M. Response of plasma prorenin and active renin to chronic and acute alterations of renin secretion in normal humans. Studies using a direct immunoradio- metric assay. J Clin Invest. 1989;83:679-687.
23. Marchetti P, Bugliani M, Lupil R, Marselli L, Masini M, Boggi U, Filipponi F, Weir GC, Eizirik DL, Cnop M. The endoplasmic reticulum in pancreatic beta cells of type 2 diabetes patients. Diabetologia. 2007; 50:2486-2494.
24. Brands MW, Fitzgerald SM. Arterial pressure control at the onset of type I diabetes: the role of nitric oxide and the renin-angiotensin system. Am J Hypertens. 2001;14:126S-131S.
25. Kim S, Hosoi M, Nakajima K, Yamamoto K. Immunological evidence that kidney is primary source of circulating inactive prorenin in rats. Am J Physiol. 1991;260:E526-E536.
26. Hosoi M, Kim S, Tabata T, Nishitani H, Nishizawa Y, Morii H, Murakami K, Yamamoto K. Evidence for the presence of differently glycosylated forms of prorenin in the plasma of anephric man. J Clin Endocrinol Metab. 1992;74:680-684.
27. Komlosi P, Fuson AL, Fintha A, Peti-Peterdi J, Rosivall L, Warnock DG, Bell PD. Angiotensin I conversion to angiotensin II stimulates cortical collecting duct sodium transport. Hypertension. 2003;42: 195-199.
28. Peti-Peterdi J, Warnock DG, Bell PD. Angiotensin II directly stimulates ENaC activity in the cortical collecting duct via AT(1) receptors. JAm Soc Nephrol. 2002;13:1131-1135.
29. Nguyen G. Increased cyclooxygenase-2, hyperfiltration, glomeruloscle- rosis, and diabetic nephropathy: put the blame on the (pro)renin receptor? Kidney Int. 2006;70:618 -620.
30. Nguyen G, Delarué F, Burckle C, Bouzhir L, Giller T, Sraer J-D. Pivotal role of the renin/prorenin receptor in angiotensin II production and cellular responses to renin. J Clin Invest. 2002;109:1417-1427.
31. Deinum J, Roønn B, Mathiesen E, Derkx FH, Hop WC, Schalekamp MA. Increase in serum prorenin precedes onset of microalbuminuria in patients with insulin-dependent diabetes mellitus. Diabetologia. 1999;42:1006-1010.
32. Saris JJ, 't Hoen PA, Garrelds IM, Dekkers DH, den Dunnen JT, Lamers JM, Jan Danser AH. Prorenin induces intracellular signaling in cardio- myocytes independently of angiotensin II. Hypertension. 2006;48:564-571.